Chylopericardium was first described by Hasebrock in 1888 (1).
She was discharged without recurrence of her effusion and is convalescing well on an unrestricted diet with no evidence of recurrent chylopericardium on evaluation with a chest radiograph and echocardiogram 1 month later.
A review in 1935 identified only three cases of chylopericardium (12), and a more comprehensive review in 2006 identified 33 reported cases, the most common etiology being idiopathic (3).
The exact mechanism of chylopericardium in this case is unknown, but the postulated mechanism is that lymphatic leak from the subcarinal, peribronchial lymph nodes and lymphatic channels (which are dissected to allow for bronchial anastomosis) creates efflux of lymph into the posterior mediastinum.
The treatment of chylopericardium should be disease specific, with the goals of decreasing chyle production, relieving or treating tamponade (16, 23, 24), or preventing secondary constrictive pericarditis (10, 25); treatment is also tailored to mitigate against the deleterious consequences of lymph depletion in regards to nutritional status, fluid and electrolyte depletion, and immunologic side effects of chronic lymphocyte reduction (25).
Chylopericardium in adults: a literature review over the past decade (19962006).
Late spontaneous chylopericardium following complex cardiac surgery.
Cervicomediastinal cystic hygroma associated with chylopericardium.
Chylothorax, chylopericardium and lymphoedema-the presenting features of signet-ring cell carcinoma.
Fatal chylopericardium caused by hamartomatous lymphangiomatosis: case report and review of the literature.